Novartis announces full takeover plans of Alcon
Novartis has proposed a full purchase of Alcon, Inc (ALC:NYSE) for a reported $39.3 billion bringing the total cash price of its Alcon acquisition to… Read More »Novartis announces full takeover plans of Alcon